iPS Cells: Mapping the Policy Issues

Amy Zarzeczny, Christopher Scott, Insoo Hyun, Jami Bennett, Jennifer Chandler, Sophie Chargé, Heather Heine, Rosario Isasi, Kazuto Kato, Robin Lovell-Badge, Kelly McNagny, Duanqing Pei, Janet Rossant, Azim Surani, Patrick L. Taylor, Ubaka Ogbogu, Timothy Caulfield

Research output: Contribution to journalComment/debate

53 Scopus citations

Abstract

Given the explosion of research on induced pluripotent stem (iPS) cells, it is timely to consider the various ethical, legal, and social issues engaged by this fast-moving field. Here, we review issues associated with the procurement, basic research, and clinical translation of iPS cells.

Original languageEnglish (US)
Pages (from-to)1032-1037
Number of pages6
JournalCell
Volume139
Issue number6
DOIs
StatePublished - Dec 11 2009
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Zarzeczny, A., Scott, C., Hyun, I., Bennett, J., Chandler, J., Chargé, S., Heine, H., Isasi, R., Kato, K., Lovell-Badge, R., McNagny, K., Pei, D., Rossant, J., Surani, A., Taylor, P. L., Ogbogu, U., & Caulfield, T. (2009). iPS Cells: Mapping the Policy Issues. Cell, 139(6), 1032-1037. https://doi.org/10.1016/j.cell.2009.11.039